Table 4.
Results of the multivariate analysis of the predictors in relation to OTC-medication use during pregnancy
| Predictor | B (regression coefficient) | Significance | OR (95%CI)* |
|---|---|---|---|
| Prescription drugs† |
0.418 |
0.101 |
1.52 (0.92-2.50) |
| Nulliparity‡ |
0.472 |
0.009 |
1.60 (1.12-2.29) |
| Comorbidity± |
0.887 |
0.000 |
2.43 (1.53-3.87) |
| Body Mass Index (kg/m2) ≠ |
0.483 |
0.022 |
1.62 (1.07-2.46) |
| 1 General Practitioner visit T |
0.224 |
0.321 |
1.25 (0.80-1.95) |
| 2 General Practitioner visits T |
0.507 |
0.063 |
1.66 (0.97-2.83) |
| ≥3 General Practitioner visits T | 0.684 | 0.028 | 1.98 (1.07-3.65) |
*Odds Ratio and the 95% confidential intervals.
† No use of prescription drugs is the reference category.
‡ Never been pregnant (nulliparity) is the reference category.
± No comorbidities is the reference category.
≠A BMI of <26 >30 kg/m2 is the reference category.
T No extra visits to the GP is the reference category.